ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 321 out of 972

$543K Total Retail Price of All Prescriptions

Rank: 277 out of 972

213 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 213 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 2,868 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
OMEPRAZOLE 457 146 1 5
RISPERIDONE 410 68 2 76
LEVOTHYROXINE SODIUM 288 67 3 3
LEVETIRACETAM 197 13 4 111
LOVASTATIN 177 124 5 22
RANITIDINE HCL 176 41 6 24
QUETIAPINE FUMARATE 169 30 7 83
FUROSEMIDE 166 71 8 7
LACTULOSE 161 30 9 211
TRIAMTERENE-HCTZ 152 100 10 39
POLYETHYLENE GLYCOL 3350 147 27 11 67
DIVALPROEX SODIUM ER 146 13 12 146
VALPROIC ACID 138 17 13 257
TOPIRAMATE 137 0 14 126
LISINOPRIL 137 107 14 1
BENZTROPINE MESYLATE 127 0 R 16 135
METFORMIN HCL 125 79 17 8
AMLODIPINE BESYLATE 120 66 18 4
DIVALPROEX SODIUM 115 0 19 96
CHLORHEXIDINE GLUCONATE 111 0 20 323
POTASSIUM CHLORIDE 109 43 21 13
NEXIUM 104 0 22 30
GEMFIBROZIL 103 22 23 93
SIMVASTATIN 102 39 24 2
WARFARIN SODIUM 102 82 24 12
FLUTICASONE PROPIONATE 99 0 26 31
DILANTIN 93 39 27 277
VIMPAT 91 0 28 348
LAMOTRIGINE 91 0 28 174
GABAPENTIN 86 42 30 14
METOPROLOL TARTRATE 85 55 31 9
SERTRALINE HCL 83 0 32 25
PRAVASTATIN SODIUM 81 15 33 20
CARBAMAZEPINE 80 15 34 203
TRIAMTERENE-HYDROCHLOROTHIAZID 80 77 34 152
ZETIA 74 33 36 79
HYDROCODONE-ACETAMINOPHEN 74 67 S3 36 6
ABILIFY 68 0 38 137
TRICOR 68 0 38 91
ZONISAMIDE 62 0 40 399
CITALOPRAM HBR 61 12 41 19
NASONEX 59 18 42 205
SEROQUEL 58 0 43 164
CALCITONIN-SALMON 57 0 44 327
ALENDRONATE SODIUM 54 37 45 27
LYRICA 53 0 46 113
MIRTAZAPINE 53 0 46 46
ZOLPIDEM TARTRATE 53 0 46 23
PERPHENAZINE 51 0 49 489
PHENYTOIN SODIUM EXTENDED 51 16 49 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.